What we did here is look at tissue in 3D and then map the genetic alterations onto that 3D model,” explained Laura Wood, M.D., Ph.D., Associate Professor of Pathology and Oncology at the Johns Hopkins ...

Pancreatic cancer develops quietly, with symptoms that may seem insignificant at first glance. This cancer affects the ...

A new study provides more evidence that GLP-1 RAs don’t raise the risk for pancreatic cancer and may in fact offer some protection.

A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a ...

These findings could pave the way for new treatment approaches for cancers driven by RAS mutations. Researchers at the ...

CODA, the first ever 3D genome profiling technique, was able to make a 3D print of pre-cancerous cells found in a human ...

Ohio State cancer researchers and surgeons are developing and deploying cutting-edge techniques to help patients.

Relevant genes to test for hereditary prostate cancer include ATM, BRCA1, BRCA2, CHEK2, HOXB13, and TP53, according to the guidelines. For all four cancer types included in these guidelines, NCCN also ...

Pancreatic cancer (PC) remains a formidable challenge in oncology due to its notoriously poor prognosis, often resulting from ...

Pancreaticobiliary cytopathology has emerged as a critical diagnostic tool, especially in evaluating pancreatic and bile duct lesions. Traditionally ...

1Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York. 2David M. Rubenstein Center for Pancreatic Cancer, Memorial Sloan Kettering ...